These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26553593)

  • 1. Alzheimer disease: Alzheimer dementia with sparse amyloid-AD mimic or variant?
    Serrano-Pozo A; Hyman BT
    Nat Rev Neurol; 2015 Dec; 11(12):674-5. PubMed ID: 26553593
    [No Abstract]   [Full Text] [Related]  

  • 2. Understanding Conflicting Neuropathological Findings in Patients Clinically Diagnosed as Having Alzheimer Dementia.
    Salloway S; Sperling R
    JAMA Neurol; 2015 Oct; 72(10):1106-8. PubMed ID: 26302229
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction and Alzheimer's disease.
    Maruszak A; Żekanowski C
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):320-30. PubMed ID: 20624441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-beta: a (life) preserver for the brain.
    Obrenovich ME; Joseph JA; Atwood CS; Perry G; Smith MA
    Neurobiol Aging; 2002; 23(6):1097-9. PubMed ID: 12470809
    [No Abstract]   [Full Text] [Related]  

  • 7. Testing times for the "amyloid cascade hypothesis".
    Hardy J
    Neurobiol Aging; 2002; 23(6):1073-4. PubMed ID: 12470803
    [No Abstract]   [Full Text] [Related]  

  • 8. Alzheimer's disease: amyloid beta-peptide antibody vaccine as plaque remover.
    Kumar A
    J Biosci; 2000 Dec; 25(4):315-6. PubMed ID: 11120582
    [No Abstract]   [Full Text] [Related]  

  • 9. Is amyloid beta-peptide neurotoxic or neuroprotective and what is its role in the binding of metal ions?
    Savory J; Ghribi O; Herman MM
    Neurobiol Aging; 2002; 23(6):1089-92. PubMed ID: 12470807
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioflocculant hypothesis: a partial endorsement.
    Terry R
    Neurobiol Aging; 2002; 23(6):1075. PubMed ID: 12470804
    [No Abstract]   [Full Text] [Related]  

  • 11. New plaque-boosting protein a possible Alzheimer target.
    Voelker R
    JAMA; 2010 Oct; 304(13):1431. PubMed ID: 20924003
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolution and the scientific method.
    Tucker HM; Estus S
    Neurobiol Aging; 2002; 23(6):1093-5. PubMed ID: 12470808
    [No Abstract]   [Full Text] [Related]  

  • 13. Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition.
    Park JH; Gimbel DA; GrandPre T; Lee JK; Kim JE; Li W; Lee DH; Strittmatter SM
    J Neurosci; 2006 Feb; 26(5):1386-95. PubMed ID: 16452662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression.
    Audrain M; Fol R; Dutar P; Potier B; Billard JM; Flament J; Alves S; Burlot MA; Dufayet-Chaffaud G; Bemelmans AP; Valette J; Hantraye P; Déglon N; Cartier N; Braudeau J
    Mol Neurodegener; 2016 Jan; 11():5. PubMed ID: 26759118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease: cholesterol a menace?
    Mathew A; Yoshida Y; Maekawa T; Kumar DS
    Brain Res Bull; 2011 Aug; 86(1-2):1-12. PubMed ID: 21741455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
    Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
    J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Amyloidosis and neurodegeneration in Alzheimer disease: who's on first?
    Knopman DS
    Neurology; 2014 May; 82(20):1756-7. PubMed ID: 24748669
    [No Abstract]   [Full Text] [Related]  

  • 18. ADDLs: a new explanation for Alzheimer disease?
    Freeman K
    Environ Health Perspect; 2003 Nov; 111(15):A810. PubMed ID: 14664240
    [No Abstract]   [Full Text] [Related]  

  • 19. Copper and Alzheimer's Disease.
    Mathys ZK; White AR
    Adv Neurobiol; 2017; 18():199-216. PubMed ID: 28889269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How
    Underwood E
    Science; 2017 Sep; 357(6357):1224. PubMed ID: 28935785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.